GALAPAGOS. PIONEERING FOR PATIENTS. WE DISCOVER. WE DARE. WE CARE. Trademark

Trademark Overview


On Tuesday, September 22, 2020, a trademark application was filed for GALAPAGOS. PIONEERING FOR PATIENTS. WE DISCOVER. WE DARE. WE CARE. with the United States Patent and Trademark Office. The USPTO has given the GALAPAGOS. PIONEERING FOR PATIENTS. WE DISCOVER. WE DARE. WE CARE. trademark a serial number of 79300854. The federal status of this trademark filing is REGISTERED as of Tuesday, March 22, 2022. This trademark is owned by Galapagos N.V.. The GALAPAGOS. PIONEERING FOR PATIENTS. WE DISCOVER. WE DARE. WE CARE. trademark is filed in the Education & Entertainment Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Education services, namely, organizing and conducting conferences, seminars, workshops and classes in the fields of chemistry, medicinal chemistry, biochemistry, biotechnology, drug discovery, drug development and pharmaceuticals for the treatment of medical disorders and dissemination of materials in connection therewith; provision of training, namely, provision of training in the fields of chemistry, medicinal chemistry, biochemistry, biotechnology, drug discovery, drug development and pharmaceuticals for the treatment of medical disorders and dissemination of materials in connection therewith

Medical services; medical and pharmaceutical advisory and consultancy services; gene bank services

Medical and scientific research services; industrial research services in the field of assay development, target discovery and validation, drug development, and medicinal chemistry; pharmaceutical and biopharmaceutical research and development services; medical and scientific research, namely, the examination and testing of genes; development, laboratory analysis, and testing of pharmaceutical and biopharmaceutical semi-finished products for use in medicaments; development, laboratory analysis, and testing of medicaments; the development of clinical assays, cellular tests, testing kits, diagnostic kits, and companion diagnostics for evaluating pharmaceutical and biopharmaceutical products of others; development of computer databases in the medical, pharmaceutical and biopharmaceutical fields; development of computer data banks containing information concerning gene expression and gene therapy; pharmaceutical drug development services
galapagos. pioneering for patients. we discover. we dare. we care.

General Information


Serial Number79300854
Word MarkGALAPAGOS. PIONEERING FOR PATIENTS. WE DISCOVER. WE DARE. WE CARE.
Filing DateTuesday, September 22, 2020
Status700 - REGISTERED
Status DateTuesday, March 22, 2022
Registration Number6674439
Registration DateTuesday, March 22, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 4, 2022

Trademark Statements


Goods and ServicesEducation services, namely, organizing and conducting conferences, seminars, workshops and classes in the fields of chemistry, medicinal chemistry, biochemistry, biotechnology, drug discovery, drug development and pharmaceuticals for the treatment of medical disorders and dissemination of materials in connection therewith; provision of training, namely, provision of training in the fields of chemistry, medicinal chemistry, biochemistry, biotechnology, drug discovery, drug development and pharmaceuticals for the treatment of medical disorders and dissemination of materials in connection therewith
Goods and ServicesMedical services; medical and pharmaceutical advisory and consultancy services; gene bank services
Goods and ServicesMedical and scientific research services; industrial research services in the field of assay development, target discovery and validation, drug development, and medicinal chemistry; pharmaceutical and biopharmaceutical research and development services; medical and scientific research, namely, the examination and testing of genes; development, laboratory analysis, and testing of pharmaceutical and biopharmaceutical semi-finished products for use in medicaments; development, laboratory analysis, and testing of medicaments; the development of clinical assays, cellular tests, testing kits, diagnostic kits, and companion diagnostics for evaluating pharmaceutical and biopharmaceutical products of others; development of computer databases in the medical, pharmaceutical and biopharmaceutical fields; development of computer data banks containing information concerning gene expression and gene therapy; pharmaceutical drug development services

Classification Information


International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status Code6 - Active
Class Status DateTuesday, January 12, 2021
Primary Code041
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, January 12, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, January 12, 2021
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGalapagos N.V.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBE

Party NameGalapagos N.V.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBE

Party NameGalapagos N.V.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBE

Trademark Events


Event DateEvent Description
Sunday, September 11, 2022FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, August 12, 2022GENERIC MADRID TRANSACTION SENT TO IB
Friday, August 12, 2022GENERIC MADRID TRANSACTION CREATED
Wednesday, June 22, 2022FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, March 22, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, January 4, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 4, 2022PUBLISHED FOR OPPOSITION
Saturday, January 1, 2022NOTIFICATION PROCESSED BY IB
Wednesday, December 15, 2021NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, December 15, 2021NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, December 15, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, December 1, 2021LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, November 30, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, October 28, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 28, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 28, 2021ASSIGNED TO LIE
Saturday, October 23, 2021TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Friday, October 1, 2021NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, October 1, 2021LETTER OF SUSPENSION E-MAILED
Friday, October 1, 2021SUSPENSION LETTER WRITTEN
Tuesday, August 31, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, August 30, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 30, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, March 22, 2021REFUSAL PROCESSED BY IB
Tuesday, March 2, 2021NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, March 2, 2021REFUSAL PROCESSED BY MPU
Tuesday, February 23, 2021NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, February 22, 2021NON-FINAL ACTION WRITTEN
Tuesday, February 9, 2021ASSIGNED TO EXAMINER
Saturday, January 16, 2021APPLICATION FILING RECEIPT MAILED
Tuesday, January 12, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, January 12, 2021LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, December 24, 2020SN ASSIGNED FOR SECT 66A APPL FROM IB